Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT02497898 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Treatment of CIK for Patients With Refractory Non-Hodgkin Lymphoma

StatusNot Yet Recruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
The purpose of this study is to study the safety and efficacy of chemotherapy usage followed by CIK transfusion in refractory and/or chemoresistant lymphomas.
Trial Details
NCT Number NCT02497898
Lead Sponsor The First People's Hospital of Changzhou
Conditions
(from sponsor)		 Lymphoma, Non-Hodgkin
Related terms Lymphoma, Non-Hodgkin
Enrollment 1,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov